相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Failure of Herpes Simplex Virus Glycoprotein D Antibodies to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines
Aakash Mahant et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice
Xingxing Li et al.
EMERGING MICROBES & INFECTIONS (2022)
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Katie J. Ewer et al.
NATURE MEDICINE (2021)
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Peng Zhang et al.
NATURE MEDICINE (2021)
Use of the Guinea pig model of genital herpes to evaluate vaccines and antivirals: Review
David Bernstein
ANTIVIRAL RESEARCH (2020)
Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4+ and CD8+ TRM Cells Associated with Protection against Recurrent Genital Herpes
Ruchi Srivastava et al.
JOURNAL OF VIROLOGY (2019)
Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes
David Bernstein et al.
VACCINE (2019)
The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes
David Bernstein et al.
VACCINE (2019)
Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial
Janine R. Danko et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Evaluation of recombinant adenovirus vaccines based on glycoprotein D and truncated UL25 against herpes simplex virus type 2 in mice
Wei Liu et al.
MICROBIOLOGY AND IMMUNOLOGY (2017)
A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus
Yangtao Wu et al.
VACCINE (2017)
Optimized DNA Vaccine Enhanced by Adjuvant IL28B Induces Protective Immune Responses Against Herpes Simplex Virus Type 2 in Mice
Yan Zhou et al.
VIRAL IMMUNOLOGY (2017)
A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs
Jared M. Odegard et al.
VACCINE (2016)
A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2015)
Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease
Christopher Petro et al.
ELIFE (2015)
Herpes Simplex Vaccines: Prospects of Live-Attenuated HSV Vaccines to Combat Genital and Ocular Infections
Brent Stanfield et al.
CURRENT CLINICAL MICROBIOLOGY REPORTS (2015)
Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?
William P. Halford
EXPERT REVIEW OF VACCINES (2014)
An Adjuvanted Herpes Simplex Virus 2 Subunit Vaccine Elicits a T Cell Response in Mice and Is an Effective Therapeutic Vaccine in Guinea Pigs
Mojca Skoberne et al.
JOURNAL OF VIROLOGY (2013)
Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine
Fernanda Tavares et al.
VACCINE (2013)
Targeting the Genital Tract Mucosa with a Lipopeptide/Recombinant Adenovirus Prime/Boost Vaccine Induces Potent and Long-Lasting CD8+ T Cell Immunity against Herpes: Importance of MyD88
Xiuli Zhang et al.
JOURNAL OF IMMUNOLOGY (2012)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori et al.
JOURNAL OF VIROLOGY (2012)
Viral vectors as vaccine platforms: deployment in sight
Christine S. Rollier et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Immunization with Herpes Simplex Virus 2 (HSV-2) Genes plus Inactivated HSV-2 Is Highly Protective against Acute and Recurrent HSV-2 Disease
Christopher S. Morello et al.
JOURNAL OF VIROLOGY (2011)
Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes
David W. Kimberlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques
Izabela Bialuk et al.
VACCINE (2011)
Diversity in CD8+ T Cell Function and Epitope Breadth Among Persons with Genital Herpes
Kerry J. Laing et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines
Ruth H. Florese et al.
JOURNAL OF IMMUNOLOGY (2009)
Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa
Esther E. Freeman et al.
VACCINE (2009)
Herpes simplex: Insights on pathogenesis and possible vaccines
David M. Koelle et al.
ANNUAL REVIEW OF MEDICINE (2008)
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
Katharine J. Looker et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Asymptomatic shedding of herpes simplex virus 1 and 2: Implications for prevention of transmission
Gregory J. Mertz
JOURNAL OF INFECTIOUS DISEASES (2008)
Herpesvirus assembly: a tale of two membranes
Thomas C. Mettenleiter et al.
CURRENT OPINION IN MICROBIOLOGY (2006)
Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes
Nancy Hosken et al.
JOURNAL OF VIROLOGY (2006)
Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors
SM Sumida et al.
JOURNAL OF VIROLOGY (2004)
Glycoprotein-D-adjuvant vaccine to prevent genital herpes
LR Stanberry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM)
SA Connolly et al.
JOURNAL OF VIROLOGY (2002)
Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation
A Jacquet et al.
VACCINE (2002)
Putative immunodominant human immunodeficiency virus-specific CD8+ T-Cell responses cannot be predicted by major histocompatibility complex class I haplotype
MR Betts et al.
JOURNAL OF VIROLOGY (2000)
分享论文
